We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Blood Test to Improve Diagnosis and Management of ALS

By LabMedica International staff writers
Posted on 27 Feb 2025

Amyotrophic lateral sclerosis (ALS) is often challenging to diagnose and predict in terms of disease progression. More...

An effective biomarker would be invaluable—not only in assisting with diagnosis but also in predicting prognosis, assessing disease stages, and monitoring patient progress or their response to treatment. Now, a new study has identified which blood tests are most effective for identifying and tracking ALS.

Researchers at Inserm Hospital (Paris, France) and University of Montpellier (Montpellier, France) conducted a study comparing three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins, and phosphorylated tau 181. Neurofilament light chain proteins are detectable in the blood when nerve cells are injured or die. Glial acidic proteins are released when the body attempts to repair such injuries, while phosphorylated tau 181 is linked to amyloid protein accumulation, a hallmark of Alzheimer’s disease. The study also assessed four different techniques to measure neurofilament light chain levels. The study, published in Neurology, involved 139 individuals diagnosed with ALS and 70 individuals with similar conditions such as lower motor neuron disease and primary lateral sclerosis. The participants’ blood was tested for these three biomarkers.

The study followed the ALS patients for an average of 3.5 years and the non-ALS group for approximately 12 years. During this period, 86% of the ALS patients passed away, compared to only 8% of those with other conditions. For neurofilament light chain proteins, those with ALS had levels three times higher in their blood compared to individuals with other diseases. The study found that tests measuring neurofilament light chain proteins accurately identified ALS patients over 80% of the time. In contrast, the accuracy of tests for glial acidic proteins and phosphorylated tau 181 was much lower, yielding correct results only about 50% of the time. Additionally, the researchers identified a specific threshold level of neurofilament light chain proteins that could predict survival in ALS patients. Within a year, over 40% of those with protein levels below the threshold were still alive, while none of those with higher protein levels survived.

“While more research needs to be done to confirm these findings, having better information about prognosis is valuable for people with ALS and their families as well as the doctors who treat them,” said study author Sylvain Lehmann, MD, PhD.


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
Clostridium Difficile Test
Immunocard Toxins A&B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.